Skip to main navigation Skip to search Skip to main content

ZIF-C for targeted RNA interference and CRISPR/Cas9 based gene editing in prostate cancer

  • Arpita Poddar
  • , Suneela Pyreddy
  • , Francesco Carraro
  • , Sudip Dhakal
  • , Andrea Rassell
  • , Matthew R. Field
  • , T. Srinivasa Reddy
  • , Paolo Falcaro
  • , Cara M. Doherty
  • , Ravi Shukla

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Gene therapy is highly suited for prostate cancer (PC). Metal-organic-frameworks (MOFs) are potential gene delivery systems. Target-specific cytoplasmic and nuclear knockdown in host gene expression using ZIF-C is shown for the first time through RNAi and CRISPR/Cas9 based gene editing in PC cells. A green tea phytochemical coating enhances intracellular delivery.

Original languageEnglish
Pages (from-to)15406-15409
Number of pages4
JournalChemical Communications
Volume56
Issue number98
DOIs
Publication statusPublished - 21 Dec 2020
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this